Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
acib is an Austrian non-profit industrial biotechnology research organization that operates at the interface of academia and industry. The center develops biocatalytic, microbial, bioprocess, biopharmaceutical, diagnostic, and bio-based manufacturing technologies for pharmaceutical, biotech, chemical, food, feed, agriculture, materials, and environmental applications. Rather than a single-asset therapeutics developer, acib functions as a collaborative R&D and innovation platform supporting translational research, contract research, and technology transfer with large pharma, biotech companies, startups, and academic institutions. Its work spans enzyme engineering, synthetic biology, cell engineering, downstream processing, diagnostics, and renewable-resource biorefineries, with a stated focus on enabling a bio-based circular economy and better health for all. The organization is publicly owned by Austrian universities and research institutions and is funded in part through the COMET competence center program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on acib.